03:15pm Tuesday 22 August 2017

Scientists uncover source of ovarian stem-like cells prone to give rise to ovarian cancer

The team demonstrated that when two important tumor suppressor genes are inactivated, a previously unknown subset of ovarian stem-like epithelial cells undergoes cancerous transformation. The findings, published today in the journal Nature, have important implications for our knowledge about ovarian cancer. 

“Sources of cells that make ovarian tumors are not really known,” says Grigori Enikolopov, Ph.D., one of the co-authors and team leader at CSHL. Dr. Alexander Nikitin is the corresponding author and team leader at Cornel University. “We demonstrated that a stem cell population sits in a portion of the ovary called the hilum, and can repair the ruptures of the ovarian tissue during ovulation, and that these cells are easily transformed into tumor cells,” Enikolopov explains.

enikopolov-22013  Cells that originate in the hilum (H, arrow) of the ovary (OV), as denoted in the purple color by the stain tdTomato, have migrated to sites in the whole surface epithelium covering the ovary (OSE). This implies that the hilum is a stem cell niche supplying cells to regenerate the ovarian surface after rupture due to ovulation. Other labels: B, bursa; UT, uterine tube. White bar is equivalent to a size of 600 μm. (click to enlarge)
The idea that cells with stem cell properties can spontaneously mutate to become seeds of cancer has been gaining momentum. Some epithelial cancers such as cancers of the ovary and the intestine are known to originate in the transition regions between different types of epithelial cells, but the exact source of such cells in the ovary has not been defined. Previous findings have suggested that cells in these transition regions may be more “plastic” and exist in a less mature (i.e., less “differentiated”) state, making them potential candidates as a cancer source. Until now, however, the lack of direct experimental evidence has made this hypothesis difficult to confirm.

The new work demonstrates that there is a population of slow-proliferating epithelial cells in the mouse ovary that can self-renew and expresses high levels of aldehyde hedydrogenase 1, or ALDH1, a known stem cell marker. The team found that these cells were localized in the ovary’s hilum region, where they normally function to repair the ruptured epithelium after ovulation.

The researchers malignantly transformed hilum epithelial cells by shutting off tumor suppressor genes Trp53 and Rb1 and then transplanted these cells into mice.  Seven of eight mice developed metastatic ovarian tumors. Trp53 and Rb1 are known to frequently mutate in human ovarian cancers.

“Some broad implications are that similar epithelial transition/junction areas can be the source of stem-like cells susceptible to malignant transformation in other organs, such as the uterine cervix and the esophagus, and become the seeds of cancer there,” Enikolopov says.  “Now we know what sort of cells to look for.”

This work was supported by grants from NIH/NCI (CA096823 and CA112354), NYSTEM (C023050 and N11G-160), and Marsha Rivkin Center for Ovarian Cancer Research; NIH/NIMH (MH092928), NIH/NIA (AG040209), NYSTEM (C024323) and the Russian Ministry of Education and Science; and NIH/NICHD T32HD052471 and the Cornell Comparative Cancer Biology Training Program.

“Ovarian surface epithelium at the junction area contains cancer-prone stem cell niche” appears online ahead of print March 6, 2013 in Nature.  The authors are: Andrea Flesken-Nikitin, Chang-Il Hwang, Chieh-Yang Cheng, Tatyana V. Michurina, Grigori Enikolopov and Alexander Yu. Nikitin.  The paper can be obtained at www.nature.org using the DOI: 10.1038/nature11979

About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. CSHL is ranked number one in the world by Thomson Reuters for impact of its research in molecular biology and genetics. The Laboratory has been home to eight Nobel Prize winners. Today, CSHL’s multidisciplinary scientific community is more than 360 scientists strong and its Meetings & Courses program hosts more than 12,500 scientists from around the world each year to its Long Island campus and its China center. Tens of thousands more benefit from the research, reviews, and ideas published in journals and books distributed internationally by CSHL Press. The Laboratory’s education arm also includes a graduate school and programs for undergraduates as well as middle and high school students and teachers. CSHL is a private, not-for-profit institution on the north shore of Long Island. For more information, visit www.cshl.edu.

Written by: Yevgeniy Grigoryev, guest science writer | Contact: tarr@cshl.edu | 516-367-8455

Share on:


Health news